Anthropic Buys Stealth Dimension-Backed Coefficient Bio in $400M+ Stock Deal - Newcomer | Substack

Anthropic has acquired Coefficient Bio, a stealth-stage biotech startup backed by Dimension, in a stock deal valued at over $400 million, signaling Anthropic's expansion into the life sciences sector.

4/3/2026

Corridor Raises $25M Series A at $200M Valuation - The SaaS News

Corridor has successfully closed a $25M Series A funding round at a $200M valuation, marking a significant milestone for the SaaS company as it looks to scale its operations and expand its market presence.

3/20/2026

Investors talk AI and health in SF at Lux event - Axios

Investors gathered in San Francisco at a Lux Capital event to discuss the intersection of artificial intelligence and healthcare, exploring emerging opportunities and trends shaping the future of both industries.

3/5/2026

Lux Capital’s Big Warning - The Information

Lux Capital issues a major warning regarding current trends in the venture capital and technology investment landscape, highlighting potential risks and challenges ahead for the industry.

3/3/2026

Maritime Defense AI Could Be the Next Big Investment Opportunity in Venture Capital - Institutional Investor

Maritime defense AI is emerging as a promising venture capital investment opportunity, attracting interest from investors seeking growth in defense technology sectors.

2/20/2026

Terra Industries raises additional $22m led by Lux Capital - africaprivateequitynews.com

Terra Industries has secured an additional $22 million in funding, led by Lux Capital, boosting its growth and expansion efforts in the African market.

2/18/2026

Japan's JIC commits $50 million to Lux Capital deep-tech fund - Asian Investor

Japan Investment Corporation (JIC) has committed $50 million to Lux Capital's deep-tech focused fund, marking a significant cross-border investment move aimed at gaining exposure to cutting-edge technology ventures.

2/9/2026

Lux Capital closes $1.5bn fund three months after launch - Alternatives Watch

Lux Capital successfully closed a $1.5 billion fund just three months after its launch, highlighting strong investor demand for the venture capital firm's latest offering.

1/9/2026

Lux Capital completes fundraising for oversubscribed Fund IX with $1.5bn - venturecapitaljournal.com

Lux Capital has successfully closed its oversubscribed Fund IX at $1.5 billion, marking a significant milestone for the venture capital firm focused on emerging science and technology investments.

1/8/2026

Anduril-backer Lux Capital lands $1.5B for its biggest fund yet to back defence and frontier AI - Tech Funding News

Lux Capital, known for backing defense tech firm Anduril, has raised $1.5 billion for its largest fund to date, focusing on defense technology and frontier AI investments.

1/8/2026

Lux Capital Raises $1.5 billion for Fund Focused on New Science, Defense - Bloomberg.com

Lux Capital has raised $1.5 billion for a new fund targeting emerging science and defense sectors, signaling growing investor interest in deep tech and national security-related ventures.

1/7/2026

Lux Capital lands $1.5B for its largest fund ever - Yahoo Finance

Lux Capital has secured $1.5 billion for its largest fund to date, marking a significant milestone for the venture capital firm focused on emerging science and technology investments.

1/7/2026

Entrepreneurs share insights at Eclectic Convergence 2025 - Cornell Chronicle

Entrepreneurs gathered at Eclectic Convergence 2025 at Cornell to share insights and experiences on innovation and business, inspiring the next generation of leaders.

11/6/2025

I played a VC firm's risk game about fake drugs. It revealed unsettling truths about AI and attention. - Business Insider

A writer played a risk simulation game created by a VC firm involving counterfeit drugs, uncovering uncomfortable insights about how AI affects human attention and decision-making.

9/21/2025

Lux Capital’s Josh Wolfe on How the Venture-Capital Firm Is Turning Sci-Fi Into ‘Sci-Fact’ - Barron's

Lux Capital's Josh Wolfe discusses how the venture-capital firm invests in cutting-edge science and technology to transform science fiction concepts into real-world breakthroughs.

9/6/2025